tiprankstipranks
Advertisement
Advertisement

JP:4552 Stock Latest News

JCR Pharmaceuticals Corrects FY2025 Results as Profit Rebounds and Dividend Held Steady
Company AnnouncementsJCR Pharmaceuticals Corrects FY2025 Results as Profit Rebounds and Dividend Held Steady
9d ago
4552
JCR Pharmaceuticals Corrects FY2024 Results as Weak Performance Prompts Closer Scrutiny
PremiumCompany Announcements
JCR Pharmaceuticals Corrects FY2024 Results as Weak Performance Prompts Closer Scrutiny
9d ago
4552
JCR Pharmaceuticals to Grant Restricted Treasury Shares as Long-Term Incentive
PremiumCompany Announcements
JCR Pharmaceuticals to Grant Restricted Treasury Shares as Long-Term Incentive
9d ago
4552
JCR Deepens Strategic Alliance With Major Shareholder MEDIPAL While Maintaining Independence
PremiumCompany Announcements
JCR Deepens Strategic Alliance With Major Shareholder MEDIPAL While Maintaining Independence
9d ago
4552
JR-446 Trial Signals Early Rare-Disease Catalyst for Medipal and JCR
PremiumCompany Announcements
JR-446 Trial Signals Early Rare-Disease Catalyst for Medipal and JCR
21d ago
JCR Pharmaceuticals Corrects Q1 FY2025 Results While Maintaining Full-Year Profit Outlook
PremiumCompany AnnouncementsJCR Pharmaceuticals Corrects Q1 FY2025 Results While Maintaining Full-Year Profit Outlook
2M ago
4552
JCR Pharmaceuticals Issues Partial Corrections to FY2024 Consolidated Results Amid Challenging Year
Premium
Company Announcements
JCR Pharmaceuticals Issues Partial Corrections to FY2024 Consolidated Results Amid Challenging Year
2M ago
4552
JCR Pharmaceuticals Corrects Interim Results but Confirms FY2025 Outlook and Dividend Plan
Premium
Company Announcements
JCR Pharmaceuticals Corrects Interim Results but Confirms FY2025 Outlook and Dividend Plan
2M ago
4552
JCR Pharmaceuticals Revises Past Financial Results After Accounting Error Review
PremiumCompany Announcements
JCR Pharmaceuticals Revises Past Financial Results After Accounting Error Review
2M ago
4552
JCR Pharmaceuticals Corrects Nine-Month FY2025 Earnings Disclosure
PremiumCompany Announcements
JCR Pharmaceuticals Corrects Nine-Month FY2025 Earnings Disclosure
2M ago
4552
JCR Pharmaceuticals Issues Cautious FY2025 Results Briefing Notice
PremiumCompany Announcements
JCR Pharmaceuticals Issues Cautious FY2025 Results Briefing Notice
2M ago
4552
JCR Pharmaceuticals Returns to Profit but Warns of Earnings Drop Amid Sales Growth
PremiumCompany Announcements
JCR Pharmaceuticals Returns to Profit but Warns of Earnings Drop Amid Sales Growth
2M ago
4552
JCR Pharmaceuticals Raises Earnings Outlook on Firm Sales and FX Gains
PremiumCompany AnnouncementsJCR Pharmaceuticals Raises Earnings Outlook on Firm Sales and FX Gains
2M ago
4552
JCR Pharmaceuticals Overhauls Leadership and Structure to Drive Global Biopharma Growth
Premium
Company Announcements
JCR Pharmaceuticals Overhauls Leadership and Structure to Drive Global Biopharma Growth
4M ago
4552
JCR Pharmaceuticals Swings Back to Profit and Lifts Full-Year Outlook
Premium
Company Announcements
JCR Pharmaceuticals Swings Back to Profit and Lifts Full-Year Outlook
5M ago
4552
JCR Books ¥1.88 Billion Government Subsidy as Extraordinary Income for Q3 FY2025
PremiumCompany Announcements
JCR Books ¥1.88 Billion Government Subsidy as Extraordinary Income for Q3 FY2025
5M ago
4552
JCR Pharmaceuticals Issues FY2025 Q3 Results Briefing With Caution on Outlook
PremiumCompany Announcements
JCR Pharmaceuticals Issues FY2025 Q3 Results Briefing With Caution on Outlook
5M ago
4552
JCR Pharmaceuticals Lifts Sales Outlook but Slashes Profit Forecast on Higher R&D and Costs
PremiumCompany Announcements
JCR Pharmaceuticals Lifts Sales Outlook but Slashes Profit Forecast on Higher R&D and Costs
5M ago
4552
JCR Pharmaceuticals Briefs Investors on New Agreement with Italfarmaco
PremiumCompany Announcements
JCR Pharmaceuticals Briefs Investors on New Agreement with Italfarmaco
5M ago
4552
JCR Pharmaceuticals Strikes Exclusive Japan Deal With Italfarmaco for DMD Drug Givinostat
PremiumCompany AnnouncementsJCR Pharmaceuticals Strikes Exclusive Japan Deal With Italfarmaco for DMD Drug Givinostat
6M ago
4552
JCR Pharmaceuticals Reports Strong Financial Recovery in First Half of FY2025
Premium
Company Announcements
JCR Pharmaceuticals Reports Strong Financial Recovery in First Half of FY2025
8M ago
4552
JCR Pharmaceuticals’ JR-141 Study: A Promising Update for Hunter Syndrome Treatment
Premium
Company Announcements
JCR Pharmaceuticals’ JR-141 Study: A Promising Update for Hunter Syndrome Treatment
8M ago
4552

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >